Rovelizumab is a humanized monoclonal leukointegrin antibody. Rovelizumab is a monoclonal antibody directed against the CD11/CD18 cell adhesion proteins. Rovelizumab can be used for research of multiple sclerosis (MS), hemorrhagic shock, myocardial infarction (MI) and stroke.
Purity:
>97.0%
CAS Number:
[339086-79-2]
Target:
Integrin
* VAT and and shipping costs not included. Errors and price changes excepted